Mowery & Schoenfeld Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Hold
1,510
2.47% 10
2026
Q1
$1.39M Sell
1,510
-89
-6% -$90.2K 2.12% 13
2025
Q4
$1.72M Buy
1,599
+89
+6% +$85.1K 2.49% 10
2025
Q3
$1.15M Sell
1,510
-20
-1% -$14.9K 1.98% 12
2025
Q2
$1.19M Sell
1,530
-8
-0.5% -$6.22K 1.81% 11
2025
Q1
$1.27M Buy
1,538
+8
+0.5% +$6.66K 2.49% 7
2024
Q4
$1.18M Buy
1,530
+157
+11% +$130K 2.3% 8
2024
Q3
$1.22M Hold
1,373
1.92% 10
2024
Q2
$1.24M Hold
1,373
1.79% 9
2024
Q1
$1.07M Hold
1,373
2.06% 10
2023
Q4
$800K Buy
+1,373
New +$801K 1.62% 12

Other funds holding LLY

Mowery & Schoenfeld Wealth Management's LLY Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,510 shares worth $1.81M. The position accounts for 2.47% of the portfolio, ranked #10.

Mowery & Schoenfeld Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management held 1,510 shares of Eli Lilly worth $1.81M as of Q2 2026.
  • Mowery & Schoenfeld Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 2.47% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #10 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.